Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Adrenocortical Carcinoma × Adrenalectomy × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Adrenal Gland Neoplasms 5 Adrenal incidentaloma 3 Pheochromocytoma 2 Cushing Syndrome 2 Urinary Bladder Neoplasms 1 Osteoporosis 1 Obesity 1 Hypertension 1 Hypercholesterolemia 1 Diabetes Mellitus 1 Carcinoma, Renal Cell 1 Adrenocortical Carcinoma 1

Interventions

Mitotane 9 Cisplatin 7 pembrolizumab 6 Specimen Handling 4 Nivolumab 4 Magnetic Resonance Spectroscopy 4 Etoposide 4 Doxorubicin 4 relacorilant 3 Cytoreduction Surgical Procedures 3 sodium thiosulfate 2 cixutumumab 2 cemiplimab 2 camrelizumab 2 cabozantinib 2 apatinib 2 Trastuzumab 2 Suramin 2 Ipilimumab 2 Cyclophosphamide 2 tipifarnib 1 lenvatinib 1 iodophenyl metomidate 1 gossypol acetic acid 1 fludarabine phosphate 1 entinostat 1 dostarlimab 1 cabazitaxel 1 antineoplaston AS 2-1 1 antineoplaston A10 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05763524 2023-03-20

LACC

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Adrenocortical Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡